Weekly online symptom reports from adults being treated for breast, lung, ovarian, blood cancers
Collects weekly online symptom reports from adults on active cancer treatment.
Plain-language title generated from the registry record
Registry title: Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Key facts
- Where
- Canton, Chapel Hill, Cleveland, Durham, Evanston, Massillon, and New Haven, United StatesSee the 7 sites
Where in United States
- Cleveland Clinic Mercy HospitalCanton, United StatesTaking people
- Univeristy of North Carolina at Chapel HillChapel Hill, United StatesNo longer taking part
- University Hospitals Seidman Cancer CenterCleveland, United StatesTaking people
- DukeDurham, United StatesNo longer taking part
- Northshore University Health SystemEvanston, United StatesTaking people
- Tri-County Hematology & Oncology Associates, Inc.Massillon, United StatesTaking people
- Yale Cancer CenterNew Haven, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Carevive Systems, Inc.
- Trial code
- NCT05974150
- Record updated
- 30 October 2026
- Original description
The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment.Read full original descriptionShow less
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia (AML) Using Remote Symptom Monitoring
The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment.
Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.
Inclusion: All participants must be 18 years of age or older; Subjects may be any stage and anywhere in the treatment continuum; Subject participants must have a diagnosis of a breast, lung, AML, ovarian cancer or multiple myeloma; Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer; All participants must be able to understand English.
Exclusion: Any patient who cannot understand written or spoken English; Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer; Any patient on a treatment clinical trial; Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).